Valuation : Pfizer Inc.

Market Cap 158B 136B 128B 117B 219B 15,067B 220B 1,520B 588B 7,676B 595B 582B 24,317B P/E 2026 *
17.4x
P/E 2027 * 13.6x
Enterprise Value 206B 177B 167B 152B 284B 19,585B 285B 1,976B 764B 9,978B 773B 756B 31,609B EV / Sales 2026 *
3.31x
EV / Sales 2027 * 3.37x
Free-Float
59.05%
Yield 2026 *
6.2%
Yield 2027 * 6.25%
1 day+0.07%
1 week-4.27%
Current month-2.39%
1 month+3.81%
3 months+8.09%
6 months+3.62%
Current year+11.57%
1 week 27.57
Extreme 27.57
28.69
1 month 26.18
Extreme 26.18
29.21
Current year 23.62
Extreme 23.62
29.21
1 year 23.58
Extreme 23.58
29.21
3 years 20.92
Extreme 20.915
34.62
5 years 20.92
Extreme 20.915
61.71
10 years 20.92
Extreme 20.915
61.71
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 55 16/08/2026
Compliance Officer 65 01/12/2013
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
8/31/26 A Free

Chief Executive Officer

21 0.0000%
8/17/26 A Other

Chief Financial Officer

273,464 0.0048%
8/14/26 A Free

Chief Executive Officer

22 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.04%-4.27%+12.42%-18.89% 158B
+0.03%-3.09%+49.77%+91.69% 1,002B
-0.76%-2.95%+50.93%+66.34% 649B
+0.86%-4.13%+19.24%+68.37% 440B
-0.80%+0.06%+28.73%+35.45% 346B
-0.13%-14.74%+9.13%+26.71% 263B
-1.90%-2.61%-2.67%+7.41% 250B
-0.48%-11.65%+39.75%+50.82% 213B
-1.06%-1.70%-16.73%-57.36% 201B
-0.68%-2.65%+25.82%+91.64% 182B
Average -0.50%-2.48%+21.64%+36.22% 370.21B
Weighted average by Cap. -0.40%-2.82%+31.00%+53.76%

Financials

2026 *2027 *
Net sales 62.24B 53.56B 50.43B 45.95B 85.97B 5,922B 86.31B 598B 231B 3,017B 234B 229B 9,558B 59.72B 51.39B 48.39B 44.09B 82.5B 5,683B 82.83B 574B 222B 2,895B 224B 219B 9,172B
Net income 8.9B 7.66B 7.21B 6.57B 12.29B 847B 12.34B 85.47B 33.03B 431B 33.42B 32.69B 1,367B 11.08B 9.53B 8.98B 8.18B 15.31B 1,054B 15.37B 106B 41.12B 537B 41.61B 40.7B 1,702B
Net Debt 47.48B 40.86B 38.47B 35.06B 65.59B 4,518B 65.85B 456B 176B 2,302B 178B 174B 7,292B 42.88B 36.9B 34.74B 31.66B 59.23B 4,080B 59.47B 412B 159B 2,079B 161B 158B 6,586B
Logo Pfizer Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
75,000
Date Price Change Volume
09/09/26 $27.78 -0.04% 29,130,507
08/09/26 $27.79 -2.32% 31,772,942
04/09/26 $28.45 -1.25% 23,791,956
03/09/26 $28.81 -0.72% 26,724,290
02/09/26 $29.02 +1.65% 39,277,907
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
27.78USD
Average target price
28.80USD
Spread / Average Target
+3.66%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!